183 related articles for article (PubMed ID: 7855121)
21. Reversal of drug resistance in Trypanosoma cruzi and Leishmania donovani by verapamil.
Neal RA; van Bueren J; McCoy NG; Iwobi M
Trans R Soc Trop Med Hyg; 1989; 83(2):197-8. PubMed ID: 2558433
[TBL] [Abstract][Full Text] [Related]
22. Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria.
Eddaikra N; Ait-Oudhia K; Kherrachi I; Oury B; Moulti-Mati F; Benikhlef R; Harrat Z; Sereno D
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006310. PubMed ID: 29561842
[TBL] [Abstract][Full Text] [Related]
23. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
[TBL] [Abstract][Full Text] [Related]
24. Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase.
Carter KC; Hutchison S; Henriquez FL; Légaré D; Ouellette M; Roberts CW; Mullen AB
Antimicrob Agents Chemother; 2006 Jan; 50(1):88-95. PubMed ID: 16377672
[TBL] [Abstract][Full Text] [Related]
25. An experimental model system for leishmaniasis. An ultrastructural study on cultured macrophages exposed to Leishmania parasites and sodium stibogluconate.
Abok K; Fredriksson BA; Brunk U
APMIS; 1988 Jul; 96(7):589-95. PubMed ID: 2841954
[TBL] [Abstract][Full Text] [Related]
26. Biochemistry of Pentostam resistant Leishmania.
Berman JD; Edwards N; King M; Grogl M
Am J Trop Med Hyg; 1989 Feb; 40(2):159-64. PubMed ID: 2537584
[TBL] [Abstract][Full Text] [Related]
27. The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis.
Martinez S; Looker DL; Berens RL; Marr JJ
Am J Trop Med Hyg; 1988 Sep; 39(3):250-5. PubMed ID: 2845824
[TBL] [Abstract][Full Text] [Related]
28. Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance.
Bhandari V; Kumar D; Verma S; Srividya G; Negi NS; Singh R; Salotra P
Biochem Biophys Res Commun; 2013 Nov; 440(4):646-51. PubMed ID: 24103752
[TBL] [Abstract][Full Text] [Related]
29. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
Escobar P; Yardley V; Croft SL
Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640
[TBL] [Abstract][Full Text] [Related]
30. Differential gene expression analysis in antimony-unresponsive Indian kala azar (visceral leishmaniasis) clinical isolates by DNA microarray.
Singh N; Almeida R; Kothari H; Kumar P; Mandal G; Chatterjee M; Venkatachalam S; Govind MK; Mandal SK; Sundar S
Parasitology; 2007 Jun; 134(Pt 6):777-87. PubMed ID: 17306059
[TBL] [Abstract][Full Text] [Related]
31. Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure.
Grögl M; Oduola AM; Cordero LD; Kyle DE
Exp Parasitol; 1989 Jul; 69(1):78-90. PubMed ID: 2543590
[TBL] [Abstract][Full Text] [Related]
32. Identification of genetic markers in sodium antimony gluconate (SAG) sensitive and resistant Indian clinical isolates of Leishmania donovani through amplified fragment length polymorphism (AFLP).
Kumar A; Boggula VR; Sundar S; Shasany AK; Dube A
Acta Trop; 2009 Apr; 110(1):80-5. PubMed ID: 19283900
[TBL] [Abstract][Full Text] [Related]
33. Decanethiol functionalized silver nanoparticles are new powerful leishmanicidals in vitro.
Isaac-Márquez AP; Talamás-Rohana P; Galindo-Sevilla N; Gaitan-Puch SE; Díaz-Díaz NA; Hernández-Ballina GA; Lezama-Dávila CM
World J Microbiol Biotechnol; 2018 Feb; 34(3):38. PubMed ID: 29460068
[TBL] [Abstract][Full Text] [Related]
34. Leishmania donovani: genetic diversity of isolates from Sudan characterized by PCR-based RAPD.
Hamad SH; Khalil EA; Musa AM; Ibrahim ME; Younis BM; Elfaki ME; El-Hassan AM;
Exp Parasitol; 2010 Aug; 125(4):389-93. PubMed ID: 20346944
[TBL] [Abstract][Full Text] [Related]
35. In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells.
da Luz RI; Vermeersch M; Dujardin JC; Cos P; Maes L
Antimicrob Agents Chemother; 2009 Dec; 53(12):5197-203. PubMed ID: 19752271
[TBL] [Abstract][Full Text] [Related]
36. Elevated TGF-beta levels in drug-resistant visceral leishmaniasis.
Elmekki MA; Elhassan MM; Ozbak HA; Mukhtar MM
Ann Saudi Med; 2016; 36(1):73-7. PubMed ID: 26922691
[TBL] [Abstract][Full Text] [Related]
37. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
[TBL] [Abstract][Full Text] [Related]
38. Antimony-resistant Leishmania donovaniin eastern Sudan: incidence and in vitro correlation.
Abdo MG; Elamin WM; Khalil EA; Mukhtar MM
East Mediterr Health J; 2003 Jul; 9(4):837-43. PubMed ID: 15748080
[TBL] [Abstract][Full Text] [Related]
39. Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice.
Kuhlencord A; Maniera T; Eibl H; Unger C
Antimicrob Agents Chemother; 1992 Aug; 36(8):1630-4. PubMed ID: 1329624
[TBL] [Abstract][Full Text] [Related]
40. The sensitivity of Leishmania species to aminosidine.
Neal RA; Allen S; McCoy N; Olliaro P; Croft SL
J Antimicrob Chemother; 1995 May; 35(5):577-84. PubMed ID: 7592170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
